Vincent Medical Holdings Ltd
HKEX:1612
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.335
0.495
|
| Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
Abbvie Inc
NYSE:ABBV
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Realty Income Corp
NYSE:O
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Vincent Medical Holdings Ltd
Intrinsic Value
Vincent Medical Holdings Ltd. engages in the manufacture and sale of medical devices. [ Read More ]
The intrinsic value of one
Vincent Medical Holdings Ltd
stock under the Base Case scenario is
1.483
HKD.
Compared to the current market price of 0.395 HKD,
Vincent Medical Holdings Ltd
is
Undervalued by 73%.
Vincent Medical Holdings Ltd's market capitalization is 258.1m HKD.
Vincent Medical Holdings Ltd stock price is 0.395 HKD.
Vincent Medical Holdings Ltd stock price (0.395 HKD) is 73% less than its Intrinsic Value (1.483 HKD).
Vincent Medical Holdings Ltd stock price (0.395 HKD) is 80% less than its DCF Value (2.005 HKD). Open DCF Valuation
Vincent Medical Holdings Ltd stock price (0.395 HKD) is 59% less than its Relative Value (0.961 HKD). Open Relative Valuation
Vincent Medical Holdings Ltd has upside potential of 70% compared to the average analyst price target.
Open Wall St Estimates
Vincent Medical Holdings Ltd's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 11%.
Vincent Medical Holdings Ltd's ROE (Return on Equity) for the past 12 months is positive and is equal to 11%.
Vincent Medical Holdings Ltd has positive Operating Income for the last twelve months.
Vincent Medical Holdings Ltd's Revenue has grown by 14% over the past 12 months.
Vincent Medical Holdings Ltd has positive Net Income for the last twelve months.
Vincent Medical Holdings Ltd has positive three-year average ROE (Return on Equity): 14%. The company is efficient at transforming stockholders' equity into net income.
Vincent Medical Holdings Ltd has positive three-year average ROIC (Return on Invested Capital): 15%. The company is efficient at using invested capital to generate operating income.
Vincent Medical Holdings Ltd's Revenue is forecast to grow at a rate of 18% per year over the next 3 years.
Vincent Medical Holdings Ltd's Altman Z-Score is equal to 2.83.
Vincent Medical Holdings Ltd has positive Free Cash Flow for the last twelve months.
Vincent Medical Holdings Ltd's ROIC (Return on Invested Capital) has significantly decreased in the last 3 years from 28% to 11%.
Vincent Medical Holdings Ltd has positive Gross Profit for the last twelve months.
Vincent Medical Holdings Ltd's ROE (Return on Equity) has significantly decreased in the last 3 years from 33% to 11%.
Vincent Medical Holdings Ltd's Revenue has been falling by 15% per year for the last 3 years.
Vincent Medical Holdings Ltd's short-term assets (573m HKD) exceed its short-term liabilties (237m HKD).
Vincent Medical Holdings Ltd's long-term assets (787m HKD) exceed its long-term liabilties (245m HKD).
Vincent Medical Holdings Ltd's D/E (Debt to Equity) is very low and is equal to 0.04.
Vincent Medical Holdings Ltd has negative Net Debt. This means that the company has more cash and short-term investments (176m HKD) than debt (23m HKD).
Vincent Medical Holdings Ltd earns more than enough operating income (66m HKD) to safely cover interest payments on its debt (1m HKD).
Valuation Backtest
Vincent Medical Holdings Ltd
Run backtest to discover the historical profit from buying and selling
Vincent Medical Holdings Ltd
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Vincent Medical Holdings Ltd
| Current Assets | 572.7m |
| Cash & Short-Term Investments | 175.8m |
| Receivables | 187.2m |
| Other Current Assets | 209.7m |
| Non-Current Assets | 214m |
| Long-Term Investments | 32.8m |
| PP&E | 149m |
| Intangibles | 4.8m |
| Other Non-Current Assets | 27.3m |
| Current Liabilities | 236.6m |
| Accounts Payable | 59.9m |
| Accrued Liabilities | 54.7m |
| Short-Term Debt | 21m |
| Other Current Liabilities | 101.1m |
| Non-Current Liabilities | 8.1m |
| Long-Term Debt | 1.8m |
| Other Non-Current Liabilities | 6.3m |
Earnings Waterfall
Vincent Medical Holdings Ltd
|
Revenue
|
718m
HKD
|
|
Cost of Revenue
|
-477.6m
HKD
|
|
Gross Profit
|
240.4m
HKD
|
|
Operating Expenses
|
-174.5m
HKD
|
|
Operating Income
|
65.9m
HKD
|
|
Other Expenses
|
-8.6m
HKD
|
|
Net Income
|
57.3m
HKD
|
Free Cash Flow Analysis
Vincent Medical Holdings Ltd
| HKD | |
| Free Cash Flow | HKD |
Profitability Score
Profitability Due Diligence
Vincent Medical Holdings Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Vincent Medical Holdings Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Vincent Medical Holdings Ltd's solvency score is 85/100. The higher the solvency score, the more solvent the company is.
Score
Vincent Medical Holdings Ltd's solvency score is 85/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Vincent Medical Holdings Ltd
According to Wall Street analysts, the average 1-year price target for
Vincent Medical Holdings Ltd
is 0.673 HKD
with a low forecast of 0.667 HKD and a high forecast of 0.693 HKD.
Click here to dive deeper.
Price Appreciation
Price
Vincent Medical Holdings Ltd
| Average Annual Return | 35.51% |
| Standard Deviation of Annual Returns | 124.76% |
| Max Drawdown | -89% |
| Market Capitalization | 258.1m HKD |
| Shares Outstanding | 643 336 000 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Vincent Medical Holdings Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Vincent Medical Holdings Ltd. engages in the manufacture and sale of medical devices. The company employs 1,281 full-time employees The company went IPO on 2016-07-13. The firm and its subsidiaries are principally engaged in the research, development, manufacture and trade of medical devices. The Company’s products include respiratory products, Orthopaedics & Rehabilitation Products and other medical devices. The Company’s subsidiaries includes Vincent Medical Manufacturing Holdings Limited, Vincent Medical Care Holdings Limited, Vincent Medical (GuangZhou) R&D Limited, VINCENT HEALTHCARE PRODUCTS LIMITED, VINCENT MEDICAL CARE COMPANY LIMITED, Vincent Medical (Dongguan) Mfg. Co. LTD., as well as VINCENT MEDICAL MANUFACTURING CO., LIMITED, among others.
Contact
IPO
Employees
Officers
The intrinsic value of one
Vincent Medical Holdings Ltd
stock under the Base Case scenario is
1.483
HKD.
Compared to the current market price of 0.395 HKD,
Vincent Medical Holdings Ltd
is
Undervalued by 73%.
You don't have any saved screeners yet
